Genetic Dissimilarity Adrenoceptor Alpha (ERa) in Hepatitis C virus-induced Cirrhosis and HCC

Amer, Mahmoud; Elmetwalli, Alaa; Attia, Attia A.; Hassan, Ayman; Nasr Eldin, Mohamed A.

doi:10.21608/eajbsg.2023.288659

Genetic Dissimilarity Adrenoceptor Alpha (ERa) in Hepatitis C virus-induced Cirrhosis and HCC

Document Type : Original Article

Authors

¹ Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt.

² Department of Clinical Trial Research Unit and Drug Discovery, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt.

³ Department of Medical Research and Diagnostic Labs, Egyptian Liver Research Institute and Hospital, Mansoura, Egypt

10.21608/eajbsg.2023.288659

Abstract

Hepatocellular carcinoma (HCC), the fifth most common kind of cancer in the world, is a significant public health concern in Egypt. The development of HCC has been linked to genetic diversity, making the disease challenging to treat. The bulk of the chronic liver illnesses that 95% of HCC patients suffer started by viruses. HCC is a complicated condition. One of the origins of HCC is the hepatitis C virus (HCV). Though being branded to piece a part in a variety of biological courses and having evidence portentously together a carcinogenic and a preemptive influence on the liver, the importance of ERa in the expansion of HCC remains doubtful. It has been shown that those with HCV have a high level of ERa expression. This study reveals how ERa and its variants affect how hepatocarcinogenesis develops.

Keywords